Fortrea Holdings Past Earnings Performance
Past criteria checks 0/6
Fortrea Holdings has been growing earnings at an average annual rate of 79.3%, while the Life Sciences industry saw earnings growing at 16.8% annually. Revenues have been growing at an average rate of 5% per year.
Key information
79.3%
Earnings growth rate
-101.8%
EPS growth rate
| Life Sciences Industry Growth | 21.5% |
| Revenue growth rate | 5.0% |
| Return on equity | -0.2% |
| Net Margin | -0.1% |
| Next Earnings Update | 13 May 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Fortrea Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 3,109 | -3 | 337 | 0 |
| 30 Sep 23 | 3,095 | 66 | 301 | 0 |
| 30 Jun 23 | 3,081 | 140 | 293 | 0 |
| 31 Mar 23 | 3,081 | 178 | 283 | 0 |
| 31 Dec 22 | 3,096 | 193 | 280 | 0 |
| 31 Dec 21 | 3,058 | 98 | 303 | 0 |
| 31 Dec 20 | 2,580 | -359 | 268 | 0 |
Quality Earnings: FTRE is currently unprofitable.
Growing Profit Margin: FTRE is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if FTRE's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare FTRE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: FTRE is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-4.5%).
Return on Equity
High ROE: FTRE has a negative Return on Equity (-0.2%), as it is currently unprofitable.